SCHEMBL10338014

SCHEMBL10338014

CNC(=O)C1CC=C(C)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.55
TSHR P16473 3/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PTPN1 P18031 1/20 0.36
MAPK1 P28482 1/20 0.36
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNA7 P36544 1/20 0.35
POLB P06746 1/20 0.35
CASP6 P55212 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CDK9 P50750 2/20 0.34
CCNT1 O60563 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
TRPA1 O75762 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15047223 0.84 LMNA (0.53) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL10423139 0.81 LMNA (0.50) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL1037667 0.79 LMNA (0.60) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL937050 0.79 LMNA (0.60) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL937318 0.79 LMNA (0.60) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL1783157 0.79 LMNA (0.66) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL12909964 0.79 LMNA (0.66) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL15450107 0.79 LMNA (0.66) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL13853504 0.78 LMNA (0.65) LMNATSHRALDH1A1SMN1; SMN2NPC1
SCHEMBL9816400 0.78 LMNA (0.55) LMNATSHRALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004702-A None JP disclosed
US-8022206-B2 Furo[3,2-C]pyridines OSI Pharmaceuticals, LLC (US) 2011-09-20 US disclosed
US-8022206-B2 Furo[3,2-C]pyridines OSI Pharmaceuticals, LLC (US) 2011-09-20 US disclosed
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines OSI PHARMACEUTICALS, INC. 2009-08-06 US disclosed
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines OSI PHARMACEUTICALS, INC. 2009-08-06 US disclosed
JP-H024702-A INSECT PEST REPELLENT SUMITOMO CHEM CO LTD 1990-01-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines RET, MET, ERBB2 LMNA 4493/4885TSHR 344/4885ALDH1A1 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.